• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE LUER ACCESS SPLIT SEPTUM; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE LUER ACCESS SPLIT SEPTUM; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Model Number 385100
Device Problem Loss of or Failure to Bond (1068)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/11/2022
Event Type  malfunction  
Manufacturer Narrative
A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.Medical device expiration date: unknown.Device manufacture date: unknown.
 
Event Description
It was reported while using bd q-syte luer access split septum the septum lifted up.There was no report of patient impact.The following information was provided by the initial reporter: the customer reported as follows: when the hcp attached and then detached the syringe, the silicon on the q-syte septum was turned up.
 
Manufacturer Narrative
The following information has been updated: d.10 device available for eval?: yes d.10 returned to manufacturer on: 2022-05-25 h.6 investigation summary: our quality engineer inspected the sample and photographs submitted for evaluation.Bd received one used q-syte unit.Additionally, four photos were received for investigation.A gross visual inspection determined that the septum was pushed in.Further microscopic inspection found that adhesive residue was present along the entire rim of the top body and on the underside of the top disk, indicating that adequate adhesion of the septum had been achieved during manufacture of the device.During manufacturing, low bond strength (or insufficient adhesive), septum misorientation, damage to the top body of the q-syte, and damaged tooling may result in the septum being pushed in.Operator-controlled checks for bond strength and septum damage are performed to mitigate the risk from this type of defect.Additionally, preventative maintenance (pm) is performed to ensure tooling is replaced per the quality plan and the equipment is functioning properly.Pm records could not be verified as no lot number was provided.During use, a pushed in septum can occur due to excessive actuations and extraneous force.Given that the sample was returned in a used state, this scenario cannot be ruled out.Although the reported issue was confirmed, it could not be determined if the damage resulted from the manufacturing of the device or from the user environment.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored.Our business team regularly reviews the collected data for identification of emerging trends.The complaint of a partially detached septum was confirmed but the exact cause was unknown.The physical sample was returned, in addition to four customer-provided photographs.The photographs indicated the same sample state as observed in the returned sample.Evaluation of the returned sample concluded that adequate adhesive coverage had taken place during manufacture, and no potential cause for the partially detached septum was observed.
 
Event Description
It was reported while using bd q-syte luer access split septum the septum lifted up.There was no report of patient impact.The following information was provided by the initial reporter: the customer reported as follows: when the hcp attached and then detached the syringe, the silicon on the q-syte septum was turned up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD Q-SYTE LUER ACCESS SPLIT SEPTUM
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX 
Manufacturer (Section G)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX  
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key14655806
MDR Text Key298295287
Report Number9610847-2022-00212
Device Sequence Number1
Product Code FPA
UDI-Device Identifier30382903851004
UDI-Public30382903851004
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K013621
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 06/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model Number385100
Device Catalogue Number385100
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/13/2022
Initial Date FDA Received06/10/2022
Supplement Dates Manufacturer Received06/23/2022
Supplement Dates FDA Received07/22/2022
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-